Last Updated on March 17, 2023 by GlobeNewsWire
COPENHAGEN, Denmark, March 17, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
1.Details of the person discharging managerial responsibilities/person closely associated a)NameJean-Christophe May2.Reason for the notificationa)Position/statusExecutive Vice President and Chief Commercial Officer of Bavarian Nordic A/Sb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)Nature of the transactionExercise of warrantsc)Price(s) and volume(s)Price(s)Volume(s) DKK 155.8014,000d)Aggregated information Aggregated volumePrice
14,000DKK 2,181,200.00
e)Date of the transaction2023-03-16f)Place of the transactionNasdaq Copenhagen A/S, XCSE1.Details of the person discharging managerial responsibilities/person closely associated a)NameJean-Christophe May2.Reason for the notificationa)Position/statusExecutive Vice President and Chief Commercial Officer of Bavarian Nordic A/Sb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)Nature of the transactionSalec)Price(s) and volume(s)Price(s)Volume(s) DKK 181.0414,000d)Aggregated information Aggregated volumePrice
14,000DKK 2,534,614.60
e)Date of the transaction2023-03-16f)Place of the transactionNasdaq Copenhagen A/S, XCSE
About Bavarian NordicBavarian Nordic is a fully integrated vaccines company focused on the research and development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the public health preparedness. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN(R) and in-licensed technologies, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including late-stage development programs for an RSV vaccine for older adults and a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.
ContactsEurope: Rolf Sass S?rensen, Vice President Investor Relations, Tel: +45 61 77 47 43US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 12 / 2023
Attachment
